These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35639419)

  • 1. Nonalcoholic Fatty Liver Disease in Young Children with Obesity.
    Klepper C; Crimmins NA; Orkin S; Sun Q; Fei L; Xanthakos S; Mouzaki M
    Child Obes; 2023 Apr; 19(3):179-185. PubMed ID: 35639419
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage.
    Zhou L; Zhang L; Zhang L; Yi W; Yu X; Mei H; Xiao H; Wang Y; Qin H; Xiong X; Yan S; Dong H; Chen P; Chen X
    Front Endocrinol (Lausanne); 2023; 14():1224816. PubMed ID: 37720532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.
    Fermin CR; Lee AM; Filipp SL; Gurka MJ; DeBoer MD
    Metab Syndr Relat Disord; 2017 Aug; 15(6):276-282. PubMed ID: 28520503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease.
    Kraus EM; Pierce SL; Porter R; Kompaniyets L; Vos MB; Blanck HM; King RJ; Goodman AB
    Child Obes; 2024 Jan; 20(1):41-47. PubMed ID: 36862137
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease.
    Xue J; Liang S; Ma J; Xiao Y
    BMC Endocr Disord; 2022 Feb; 22(1):49. PubMed ID: 35216556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between alanine aminotransferase as surrogate of fatty liver disease and physical activity and sedentary time in adolescents with obesity.
    Julian V; Bergsten P; Ennequin G; Forslund A; Ahlstrom H; Ciba I; Dahlbom M; Furthner D; Gomahr J; Kullberg J; Maruszczak K; Morwald K; Olsson R; Pixner T; Schneider A; Pereira B; Ring-Dimitriou S; Thivel D; Weghuber D
    Eur J Pediatr; 2022 Aug; 181(8):3119-3129. PubMed ID: 35771354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
    Mohamed RZ; Jalaludin MY; Anuar Zaini A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV.
    Greber-Platzer S; Thajer A; Bohn S; Brunert A; Boerner F; Siegfried W; Artlich A; Moeckel A; Waldecker-Krebs H; Pauer S; Holl RW;
    BMC Pediatr; 2019 Sep; 19(1):332. PubMed ID: 31514755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for incidence and remission of nonalcoholic fatty liver disease in obese children and adolescents.
    Lin YC; Chang PF; Liu K; Chang MH; Ni YH
    J Formos Med Assoc; 2022 Jan; 121(1 Pt 1):36-42. PubMed ID: 33504463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.
    Kim MJ; Lee KJ
    BMC Pediatr; 2020 Mar; 20(1):121. PubMed ID: 32171275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.
    Frediani JK; Naioti EA; Vos MB; Figueroa J; Marsit CJ; Welsh JA
    Environ Health; 2018 Jan; 17(1):6. PubMed ID: 29334960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI Metrics Are Poor Predictors of Pediatric Nonalcoholic Fatty Liver Disease Severity.
    Klepper CM; Khurana T; Sun Q; Fei L; Crimmins NA; Siegel R; Mouzaki M
    Child Obes; 2023 Mar; 19(2):139-143. PubMed ID: 35475755
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of Elevated ALT in Adolescents in the US 2011-2018.
    Mischel AK; Liao Z; Cao F; Dunn W; Lo JC; Newton KP; Goyal NP; Yu EL; Schwimmer JB
    J Pediatr Gastroenterol Nutr; 2023 Jul; 77(1):103-109. PubMed ID: 37084344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased prevalence of nonalcoholic fatty liver disease in black obese children.
    Louthan MV; Theriot JA; Zimmerman E; Stutts JT; McClain CJ
    J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):426-9. PubMed ID: 16205510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity.
    Yu EL; Golshan S; Harlow KE; Angeles JE; Durelle J; Goyal NP; Newton KP; Sawh MC; Hooker J; Sy EZ; Middleton MS; Sirlin CB; Schwimmer JB
    J Pediatr; 2019 Apr; 207():64-70. PubMed ID: 30559024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease.
    Qiu J; Kuang M; Yang R; Yu C; He S; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1239398. PubMed ID: 37727457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels.
    Molleston JP; Schwimmer JB; Yates KP; Murray KF; Cummings OW; Lavine JE; Brunt EM; Scheimann AO; Unalp-Arida A;
    J Pediatr; 2014 Apr; 164(4):707-713.e3. PubMed ID: 24360992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening patterns and identification of non-alcoholic fatty liver disease in obese children in canadian primary care.
    Theal R; Morkem R; Queenan J; Barber D
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile.
    Quirós-Tejeira RE; Rivera CA; Ziba TT; Mehta N; Smith CW; Butte NF
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):228-36. PubMed ID: 17255837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
    Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X
    Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.